8-K 1 tm206420d1_8k.htm 8-K





Washington, D.C. 20549




Current Report


Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): February 3, 2020 



(Exact Name of Registrant as Specified in its Charter) 


Delaware   001-34785   20-4988129

(State or other jurisdiction 

of incorporation)



File Number)


(I.R.S. Employer

Identification No.)


254 West 31st Street, 11th Floor

New York, New York 10001

(Address of Principal Executive Offices and Zip Code)


Registrant’s telephone number, including area code: (646) 525-4319 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of each class  Trading Symbol(s)  Name of each exchange on which registered

Common stock,

par value $0.01 per share

XSPA The Nasdaq Stock Market


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company ¨


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨






Item 5.02      Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.




On February 3, 2020, Salvatore Giardina resigned as a director of XpresSpa Group, Inc. (the “Company”) and as Chairman of the Audit Committee (the “Audit Committee”) of the Board of Directors (the “Board”) of the Company, effective as of that date. Mr. Giardina’s resignation was not as a result of any disagreement with the Company on any matters related to the Company’s operations, policies or practices.




Effective as of February 3, 2020, Robert Weinstein was appointed by the Board as a director of the Company and as the Chairman of the Audit Committee. There are no arrangements or understandings between Mr. Weinstein and any other persons pursuant to which he was selected as a director, he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K and there are no family relationships between Mr. Weinstein and any director or executive officer of the Company.


Item 8.01     Financial Statements and Exhibits.


On February 3, 2020, the Company issued a press release announcing the appointment of Mr. Weinstein as a director of the Company. The full text of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.


Item 9.01 Financial Statements and Exhibits.


(d) Exhibits.


Number   Description of Exhibits
99.1   XpresSpa Group, Inc. Press Release dated February 3, 2020.







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: February 3, 2020 By:

/s/ Bruce Bernstein

    Name: Bruce Bernstein  
    Title: Chairman of the Board of Directors